List of publications

List of publications

Compter I, Verduin M, Shi Z, Woodruff HC, Smeenk RJ, Rozema T, Leijenaar RTH, Monshouwer R, Eekers DBP, Hoeben A, Postma AA, Dekker A, De Ruysscher D, Lambin P, Wee L. Deciphering the glioblastoma phenotype by Computed Tomography radiomics. Radiother Oncol. 2021 Jul

Eekers DBP, Di Perri D, Roelofs E, Postma AA, Dijkstra J, Ajithkumar T, Alapetite C, Bromstrand M, Burnet NG, Calugaru V, Compter I, Coremans IEM, Harrabi S, Iannalfi A, Klaver YLB, Lambrecht M, Méndez Romero A, Paulsen F, Timmermann B, Vitek P, van der Weide HL, Whitfield GA, Witt Nyström P, Zindler J, De Ruysscher D, Langendijk J, Weber DC, Troost EGC, MD on behalf of the taskforce “European Particle Therapy Network” of ESTRO. Update of the EPTN atlas for CT- and MR-based (3T and 7T) contouring in Neuro-Oncology. Radiother Oncol. 2021 Jul

In ‘t Ven L, Compter I, van Eijsden K, Zindler J, Swinnen A, de Ruysscher D, Rozema T, Troost EGC, Eekers DBP. A validated model to predict alopecia in brain tumor patients receiving cranial irradiation. Submitted to Radiotherapy & Oncology 2021

’t Ven L, Roelofs E, Mesías MC, Compter I, Klaver YLB, Smeenk RJ, Janssens GO, Kaanders JHAM, Fajardo RD, Oldenburger F, de Ruysscher D, Troost EGC, Eekers DBP. The ROCOCO Performance Scoring System translates dosimetric differences into clinically relevant endpoints: comparing IMPT to VMAT in an example pilocytic astrocytoma dataset. Clin Transl Radiat Oncol. 2021 Feb

Verduin M, Primakov S, Compter I, Woodruff HC, van Kuijk SMJ, Ramaekers BLT, te Dorsthorst M, Revenich EGM, ter Laan M, Pegge SAH, Meijer FJA, Beckervondersandforth J, Speel EJ, Kusters B, de Leng WWJ, Anten MM, Broen MPG, Ackermans L, Schijns OEMG, Teernstra O, Hovinga K, Vooijs MA, Tjan-Heijnen VCG, Eekers DBP, Postma AA, Lambin P, Hoeben A. Prognostic and predictive value of integrated qualitative and quantitative magnetic resonance imaging analysis in glioblastoma. Cancers. 2021 Feb

Jaspers JPM, Méndez Romero A, Wiggenraad R, Compter I, Eekers DBP, Nout RA, van den Bent M. Pattern of failure in IDH mutated, low grade glioma after radiotherapy - Implications for margin reduction. Radiother Oncol. 2020 Nov

Compter I, Eekers DBP, Hoeben A, Rouschop KMA, Reymen B, Ackermans L, Beckervordersantforth J, Bauer NJC, Anten MM, Wesseling P, Postma AA, De Ruysscher D, Lambin P. Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial. Autophagy. 2020 Sep.

Koemans WJ, Larue RTHM, Kloft M, Ruisch JE, Compter I, Riedl RG, Heij LR, van Elmpt W, Berbée M, Buijsen J, Lambin P, Sosef MN, Grabsch HI. Lymph node response to chemoradiotherapy in oesophageal cancer patients: relationship with radiotherapy fields. Esophagus. 2020 Sep.

Weis J, Wirtz MA, Tomaszewski KA, Hammerlid E, Arraras JI, Conroy T, Lanceley A, Schmidt H, Singer S, Pinto M, Alm El-Din M, Compter I, Holzner B, Hofmeister D, Chie WC, Harle A, Flechtner HH, Bottomley A; EORTC Quality of Life Group. Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): Results from the international psychometric validation. Psychooncology. 2019 Aug.

Walsh S, de Jong EEC, van Timmeren JE, Ibrahim A, Compter I, Peerlings J, Sanduleanu S, Refaee T, Keek S, Larue RTHM, van Wijk Y, Even AJG, Jochems A, Barakat MS, Leijenaar RTH, Lambin P. Decision Support Systems in Oncology. JCO Clin Cancer Inform. 2019 Feb.

Peerlings J, Compter I, Janssen F, Wiggins C, Mottaghy F, Lambin P, Hoffmann A. Characterizing geometrical accuracy in clinically optimized 7T and 3T MR images for high-precision radiation treatment of brain tumours. Physics and Imaging in Radiation Oncology. 2019 Jan.

Eekers DB, in ‘t Ven L, Roelofs E, Postma A, Alapetite C, Burnet NG, Calugaru V, Compter I, Coremans IEM, Høyer M, Lambrecht M, Nyström PW, Méndez Romero A, Paulsen F, Perpar A, de Ruysscher D, Renard L, Timmermann B, Vitek P, Weber DC, van der Weide HL, Whitfield GA, Wiggenraad R, Troost EGC; “European Particle Therapy Network” of ESTRO. The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology. Radiother Oncol. 2018 Jul.

Verduin M, Compter I, Steijvers D, Postma AA, Eekers DBP, Anten MM, Ackermans L, Ter Laan M, Leijenaar RTH, van de Weijer T, Tjan-Heijnen VCG, Hoeben A, Vooijs M. Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response. Dis Markers. 2018 Jan.

Jutten B, Keulers TG, Peeters HJM, Schaaf MBE, Savelkouls KGM, Compter I, Clarijs R, Schijns OEMG, Ackermans L, Teernstra OPM, Zonneveld MI, Colaris RME, Dubois L, Vooijs MA, Bussink J, Sotelo J, Theys J, Lammering G, Rouschop KMA. EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition. Autophagy. 2018 Jan.

Weis J, Tomaszewski KA, Hammerlid E, Ignacio Arraras J, Conroy T, Lanceley A, Schmidt H, Wirtz M, Singer S, Pinto M, Alm El-Din M, Compter I, Holzner B, Hofmeister D, Chie WC, Czeladzki M, Harle A, Jones L, Ritter S, Flechtner HH, Bottomley A; EORTC Quality of Life Group. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12). J Natl Cancer Inst. 2017 May.

Zindler JD, Jochems A, Lagerwaard FJ, Beumer R, Troost EGC, Eekers DBP, Compter I, van der Toorn PP, Essers M, Oei B, Hurkmans CW, Bruynzeel AME, Bosmans G, Swinnen A, Leijenaar RTH, Lambin P. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms. Radiother Oncol. 2017 May.

Compter I*, Peerlings J*, Eekers D. B.P, Postma A. A, Ivanov D, Wiggins C. J, Kubben P, Küsters B, Wesseling P, Ackermans L, Schijns O. E. M.G, Lambin P, Hoffmann A. L. Technical feasibility of integrating 7 Tesla anatomical MRI in image-guided radiotherapy of glioblastoma: a preparatory study. MAGMA. 2016 Jun.

Lambin P, Zindler J, Vanneste BG, De Voorde LV, Eekers D, Compter I, Panth KM, Peerlings J, Larue RT, Deist TM, Jochems A, Lustberg T, van Soest J, de Jong EE, Even AJ, Reymen B, Rekers N, van Gisbergen M, Roelofs E, Carvalho S, Leijenaar RT, Zegers CM, Jacobs M, van Timmeren J, Brouwers P, Lal JA, Dubois L, Yaromina A, Van Limbergen EJ, Berbee M, van Elmpt W, Oberije C, Ramaekers B, Dekker A, Boersma LJ, Hoebers F, Smits KM, Berlanga AJ, Walsh S. Decision support systems for personalized and participative radiation oncology. Adv Drug Deliv Rev. 2016 Jan.

Müller K, Henke G, Pietschmann S, van Gool S, De Vleeschouwer S, von Bueren AO, Compter I, Friedrich, C, Matuschek C, Klautke G, Kortmann RD, Hundsberger T, Baumert BG. Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model. J Neurooncol. 2015 Jun.

Müller K, Henke G, Compter I, von Bueren AO, Friedrich C, Janssens G, Kramm CM, Hundsberger T, Paulsen F, Kortmann RD, Zwiener I, Baumert BG. External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation. Pract Radiat Oncol. 2014 Nov.

Compter I, Zaugg K, Houben RM, Dings JT, Bosmans G, Buescher C, Anten MM, Baumert BG. High symptom improvement and local tumor control using stereotactic radiotherapy when given early after diagnosis of meningioma. A multicentre study. Strahlenther Onkol. 2012 Oct.

*indicates equal contribution

- 199 -